Data from phase 3 studies with filgotinib, gecacitinib, and ivarmacitinib and a phase 4 study of tofacitinib in early disease are reported.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/four-jak-inhibitors-have-positive-late-stage-trial-results-2026a1000k1z?src=rss
Author :
Publish date : 2026-06-15 11:07:00
Copyright for syndicated content belongs to the linked Source.
